Preventative HIV drug ‘highly effective’ – study
A little blue pill that stops HIV infecting the body is “highly effective”, a landmark study has confirmed.
The drug – HIV pre-exposure prophylaxis (PrEP) – is used by thousands of people across the UK already, having performed well in trials.
But while earlier studies were carried out in clinical settings, this was a real-world trial involving 24,000 participants across England. This gave researchers the chance to see how effective the drug is in everyday life.
“Highly effective”, is the verdict. According to the UK Health Security Agency (UKHSA), which led the research, using PrEP reduces the chances of getting HIV by 86%.
“Now we know just how effective PrEP is in real-world settings, substantially reducing the chance of acquiring HIV,” said Dr John Saunders of the UKHSA. “It’s vital that all those who can benefit from PrEP can access it.” HIV testing and PrEP is available for free from sexual health services.